Uric Acid

What Uric Acid Measures

Uric acid is the end product of purine metabolism. Above ~6.8 mg/dL it begins to crystallize in joints (gout) and kidneys (stones). Beyond that, elevated uric acid is increasingly recognized as a contributor to endothelial dysfunction and metabolic syndrome - fructose metabolism specifically raises uric acid, linking sugar intake to CV risk.

Many optimization users find uric acid trends with visceral adiposity and insulin resistance. It drops meaningfully on GLP-1-mediated weight loss.

What Affects This Biomarker

Uric acid is influenced by: purine-rich foods (organ meats, alcohol - especially beer), fructose intake, renal function (excreted 2/3 renally), thiazide diuretics (raise it), allopurinol (lowers it), dehydration, and insulin resistance. Drops on GLP-1 weight loss and ketogenic diets (with initial transient rise on keto start).

In the Context of Peptide Protocols

Trend annually in anyone with metabolic goals. Sharp rises with thiazide initiation, fasting, or rapid weight loss are expected. Consistently >7 with symptoms or family history of gout warrants specialist input.

Deep Dive

The uricase paradox: why humans run high on purpose

Most mammals keep serum urate near 1 to 2 mg/dL because they carry a working copy of uricase (urate oxidase), the enzyme that degrades urate into soluble allantoin. Humans and the great apes do not. A series of mutations silenced the uricase gene during the Miocene epoch, roughly 15 to 20 million years ago, and the result is a species that runs urate two to five times higher than almost every other animal. This is not simply a byproduct of disease. It appears to have been selected for.

The leading explanation, first argued by Ames and colleagues in a 1981 PNAS paper, is that urate is one of the most abundant antioxidants in human plasma and accounts for a large share of the blood's total antioxidant capacity. Retaining it may have offered protection against oxidative stress in a lineage that had already lost the ability to make its own vitamin C. That evolutionary backdrop is the reason this marker should not be read as "lower is always better." Urate is both a metabolic hazard at the high end and a functional antioxidant you do not want to eliminate.

Reading the number: the J-shaped curve

Standard labs flag only the high end, which is why a useful target sits inside a window rather than at a floor. Population data repeatedly show a J or U shaped relationship between urate and several outcomes. The high side is familiar: crystallization risk plus a tight association with visceral fat and cardiometabolic risk. The low side is less appreciated. Observational cohorts have linked unusually low urate to a higher burden of neurodegenerative conditions, most consistently Parkinson disease, presumably through loss of antioxidant protection.

Two cautions keep this both compliance-honest and scientifically honest. First, association is not causation. When the Parkinson Study Group deliberately raised urate with inosine in the SURE-PD3 trial, it did not slow disease progression and was stopped for futility. So a mid-range value is a reasonable thing to watch, but chasing an artificially low or high number is not supported by the evidence. The meaningful signal is usually the trend over time, not a single point, and a steady reading in the low-to-mid range is what most optimization-minded users track toward.

The fructose mechanism most explanations skip

The link between sugar and urate is specific to fructose, and the mechanism is worth understanding because it explains why the marker can move within an hour of a single drink. Fructose is phosphorylated in the liver by fructokinase (ketohexokinase), an enzyme with no meaningful feedback brake. A large fructose load consumes intracellular ATP faster than the cell can regenerate it, stripping phosphate and driving the breakdown of AMP down the purine degradation pathway that ends in uric acid.

Glucose does not do this. Its committed enzyme, phosphofructokinase, is feedback inhibited, so glucose cannot deplete cellular energy charge the same way. That is the biochemical reason a can of regular soda produces a measurable urate spike while an equivalent starch load does not, and it is why sweetened-beverage intake tracks with this marker far more tightly than total calories do. The research of Johnson, Lanaspa and colleagues mapped this pathway in detail.

Why genetics, not diet, drives most high readings

A common surprise is the lean person who eats well and still runs high. The reason is that roughly 90 percent of chronic hyperuricemia is a problem of under-excretion rather than over-production. About two thirds of urate leaves through the kidney and one third through the gut, and the transporters that handle both are strongly heritable.

Genome-wide studies, notably the Global Urate Genetics Consortium work led by Kottgen and published in Nature Genetics in 2013, confirmed SLC2A9 (GLUT9) and ABCG2 as the dominant loci. The common ABCG2 variant reduces both renal and intestinal urate clearance. In practical terms, diet typically moves serum urate by less than 1 mg/dL, while genotype can shift a baseline by 1 to 2 mg/dL. That is why this marker is best read as a personal set point tracked over time rather than a pass-or-fail dietary scorecard.

Testing pitfalls: when the number lies

Several predictable artifacts throw off a single draw:

- During an acute gout flare, serum urate is often normal or even low, because urate is precipitating into the joint rather than staying in the blood. Confirming a diagnosis from a mid-flare number is a classic error. Retest a few weeks after the flare settles. - Fasting, ketogenic adaptation, and rapid weight loss transiently raise urate. Ketoacids and lactate compete with urate at the renal urate transporters (URAT1), cutting excretion. This usually resolves over a few weeks. - Recent hard exercise, dehydration, heavy alcohol, or an organ-meat dinner the night before all inflate a reading. - High-dose vitamin C is mildly uricosuric and can nudge a value downward.

For a clean baseline, draw when well hydrated, not after a multi-day fast, not during a flare, and not the morning after intense training or drinking.

Peptide and protocol tracking context

For users running GLP-1 receptor agonists such as semaglutide or tirzepatide, expect a two-phase pattern rather than a straight line. Early, during aggressive calorie restriction and fast fat loss, urate can drift up for the same fasting and ketone reasons above. Over months, as visceral fat falls, it usually settles below the pre-protocol baseline. Reading that early rise as a failure is a common misinterpretation. Track it alongside creatinine and eGFR so a rise driven by dehydration is not confused with one driven by kidney function.

Two adjacent agents are worth noting for anyone assembling a stack with a clinician. SGLT2 inhibitors lower serum urate through a uricosuric effect, and among blood-pressure drugs losartan is mildly urate-lowering where most are neutral, whereas thiazides and low-dose aspirin push it upward. None of this is a dosing recommendation. It is context for interpreting a moving number, and a prompt to bring persistent or symptomatic elevations to a qualified clinician.

Peptides That Commonly Move Uric Acid

Frequently Asked Questions

Where This Fits in Your Panel

Uric Acid is one marker on a fuller panel. The Peptide Blood Work Checklist lays out the complete baseline panel, what to add by protocol type, and when to retest.

Upload any lab PDF and MyProtocolStack maps your values to Uric Acid and 40+ other biomarkers. StackAI interprets the trend in context of your protocol.